Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 3.23 CAD -4.44% Market Closed
Market Cap: 88.5m CAD
Have any thoughts about
Covalon Technologies Ltd?
Write Note

Covalon Technologies Ltd
Net Issuance of Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Covalon Technologies Ltd
Net Issuance of Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
Covalon Technologies Ltd
XTSX:COV
Net Issuance of Debt
-CA$694.1k
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bright Minds Biosciences Inc
CNSX:DRUG
Net Issuance of Debt
-CA$86.1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Net Issuance of Debt
-$2.2m
CAGR 3-Years
-51%
CAGR 5-Years
10%
CAGR 10-Years
N/A
ESSA Pharma Inc
NASDAQ:EPIX
Net Issuance of Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Net Issuance of Debt
-$15.5m
CAGR 3-Years
N/A
CAGR 5-Years
-180%
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Net Issuance of Debt
CA$7.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Covalon Technologies Ltd
Glance View

Market Cap
88.5m CAD
Industry
Biotechnology

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm uses science and technology to help solve medical challenges associated with prevention, detection and management of areas such as infection, tissue repair and medical devices. Its products include Advanced Wound Care, Vascular Access, Perioperative Care and Urology. Advanced Wound Care is designed for the treatment of a range of wounds and offers CovaWound and ColActive brands. Vascular Access portfolio includes CovaView IV, a transparent film dressing that provides an effective barrier against external contaminants, including fluid, bacteria, and yeast. Perioperative care refers to the three Phases of surgery, including preoperative, intraoperative, and postoperative care and its brands include MediClear and SurgiClear.

COV Intrinsic Value
2.73 CAD
Overvaluation 15%
Intrinsic Value
Price

See Also

What is Covalon Technologies Ltd's Net Issuance of Debt?
Net Issuance of Debt
-694.1k CAD

Based on the financial report for Jun 30, 2024, Covalon Technologies Ltd's Net Issuance of Debt amounts to -694.1k CAD.

What is Covalon Technologies Ltd's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 3Y
-9%

Over the last year, the Net Issuance of Debt growth was 0%. The average annual Net Issuance of Debt growth rates for Covalon Technologies Ltd have been -9% over the past three years .

Back to Top